|
GTF2H3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62610999999702E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.321500E-03 |
| Normal-vs-Stage2 |
1.082350E-02 |
| Normal-vs-Stage3 |
4.99520000030174E-07 |
| Normal-vs-Stage4 |
4.355700E-04 |
| Stage1-vs-Stage2 |
3.741800E-01 |
| Stage1-vs-Stage3 |
1.397810E-03 |
| Stage1-vs-Stage4 |
6.904100E-02 |
| Stage2-vs-Stage3 |
2.051200E-01 |
| Stage2-vs-Stage4 |
4.749200E-01 |
| Stage3-vs-Stage4 |
6.550800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19289999999761E-05 |
| Normal-vs-AfricanAmerican |
3.980100E-04 |
| Normal-vs-Asian |
6.320400E-01 |
| Caucasian-vs-AfricanAmerican |
2.696800E-01 |
| Caucasian-vs-Asian |
4.182600E-01 |
| AfricanAmerican-vs-Asian |
2.391400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.94039999998641E-06 |
| Normal-vs-Female |
6.550900E-04 |
| Male-vs-Female |
3.588200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.605800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.950200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.48829999999201E-05 |
| Normal-vs-Age(81-100Yrs) |
4.212000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.681800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.121600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.401600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.566400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.998150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.259800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.352200E-01 |
| Normal-vs-Grade 2 |
8.536300E-03 |
| Normal-vs-Grade 3 |
2.99909999945669E-07 |
| Normal-vs-Grade 4 |
1.177780E-04 |
| Grade 1-vs-Grade 2 |
5.602200E-01 |
| Grade 1-vs-Grade 3 |
1.005800E-01 |
| Grade 1-vs-Grade 4 |
2.915700E-02 |
| Grade 2-vs-Grade 3 |
3.218200E-03 |
| Grade 2-vs-Grade 4 |
2.021500E-02 |
| Grade 3-vs-Grade 4 |
6.015000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.241600E-02 |
| Normal-vs-ccB subtype |
3.73449999999664E-05 |
| ccA subtype-vs-ccB subtype |
1.839840E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.609400E-04 |
| Normal-vs-N1 |
2.419200E-01 |
| N0-vs-N1 |
8.908800E-01 |
|
|
